Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls / Yong Min Ahn en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 117-123 Título : Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls Tipo de documento: texto impreso Autores: Yong Min Ahn, Autor ; Kyu Young Lee, Autor ; Chul Eung Kim, Autor Fecha de publicación: 2022 Artículo en la página: pp. 117-123 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Amisulprida, Pacientes con esquizofrenia, Función neurocognitiva, Control saludable, Efecto de la práctica Resumen: We examined short- and long-term changes in neurocognitive functions in patients with schizophrenia who were either started or switched to amisulpride in comparison with the normal controls. Fifty-seven patients treated with amisulpride and 60 normal controls completed a comprehensive neurocognitive function test battery at the baseline, the 8-week, and the 1-year follow-up. Link: ./index.php?lvl=notice_display&id=29514 [artículo] Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls [texto impreso] / Yong Min Ahn, Autor ; Kyu Young Lee, Autor ; Chul Eung Kim, Autor . - 2022 . - pp. 117-123. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 2 (Abril) . - pp. 117-123 Palabras clave: Amisulprida, Pacientes con esquizofrenia, Función neurocognitiva, Control saludable, Efecto de la práctica Resumen: We examined short- and long-term changes in neurocognitive functions in patients with schizophrenia who were either started or switched to amisulpride in comparison with the normal controls. Fifty-seven patients treated with amisulpride and 60 normal controls completed a comprehensive neurocognitive function test battery at the baseline, the 8-week, and the 1-year follow-up. Link: ./index.php?lvl=notice_display&id=29514

---

1 (1 - 1 / 1)